Verum Partners’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.1M Buy
483,100
+28,202
+6% +$1.13M 3.01% 9
2026
Q1
$16.5M Buy
454,898
+31,773
+8% +$1.22M 3.13% 10
2025
Q4
$16.3M Buy
423,125
+16,816
+4% +$632K 3.28% 9
2025
Q3
$14.7M Buy
406,309
+33,020
+9% +$1.15M 3.13% 10
2025
Q2
$12.8M Sell
373,289
-10,411
-3% -$330K 2.95% 10
2025
Q1
$12M Buy
383,700
+20,862
+6% +$681K 3.23% 10
2024
Q4
$11.6M Buy
362,838
+18,169
+5% +$591K 3.34% 10
2024
Q3
$11.2M Buy
344,669
+43,827
+15% +$1.38M 3.29% 10
2024
Q2
$9.33M Buy
300,842
+104,615
+53% +$3.12M 3.01% 10
2024
Q1
$5.83M Buy
196,227
+140,475
+252% +$3.98M 2.07% 11
2023
Q4
$1.48M Buy
+55,752
New +$1.45M 0.59% 46

Other funds holding QLTY

Verum Partners's QLTY Position: Q2 2026 in Review

Verum Partners increased its GMO US Quality ETF (QLTY) stake by 6.2% in Q2 2026, buying an estimated $1.13M and bringing the position to 483,100 shares worth $20.1M. The position accounts for 3.01% of the portfolio, ranked #9.

Verum Partners first reported a position in QLTY in Q4 2023 and has held it in 11 quarters since. 160 funds tracked by Wall St. Rank hold QLTY as of Q2 2026.

  • Verum Partners held 483,100 shares of GMO US Quality ETF worth $20.1M as of Q2 2026.
  • Verum Partners bought 28,202 GMO US Quality ETF shares in Q2 2026, an estimated $1.13M.
  • GMO US Quality ETF made up 3.01% of Verum Partners's portfolio in Q2 2026, its #9 holding.
  • Verum Partners first reported a position in GMO US Quality ETF in Q4 2023 and has held it in 11 quarters since.
  • 160 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2026.

Based on Verum Partners's 13F filing for Q2 2026, filed 22 Jul 2026.